In the 50 mg group, the average weight loss was 17.5 pounds
Funding Supported by the grant from the Medical University of Lodz (#503/1-156-04/503-11-001 to JF)
Managing your weight and understanding your caloric needs can be challenging, especially when youre taking GLP-1 medications such as Ozempic, Wegovy, Semaglutide, Mounjaro, Zepbound, Tirzepatide, Liraglutide, Saxenda, Trulicity, and Victoza
Weight loss may improve obesity-related obstructive sleep apnea for some patients, but it does not replace proper testing or prescribed therapy
Weight loss attempts are generally less successful when thyroid function remains suboptimal
The Standard Approach and Its Limitations Most GLP-1 treatment plans escalate dosing aggressively, keep patients at the maximum dose indefinitely, and do not adjust based on how much medication a person actually needs